Skip to main content

Table 2 Validation of DASE Candidate by Sanger Sequencing

From: Identifying breast cancer risk loci by global differential allele-specific expression (DASE) analysis in mammary epithelial transcriptome

Gene ID SNP ID Heterozygous samples DASE events* by array DASE events by sequencing
ACPP rs14192 5 4 3
CHRAC1 rs10216653 6 5 1
DMBT1 rs11523871 6 6 6
MMP20 rs1784423 6 6 6
MUC16 rs2547068 6 4 3
PTTG2 rs6811863 5 5 4
SLAMF1 rs1061217 6 6 2
USP6 rs11658877 6 6 2
ZNF331 rs8110350 5 5 4
Total:   51 47 31 §
  1. *: A positive DASE event is defined when the ratio of ASE levels from one allele to another allele is either more that 2 or less that 0.5.
  2. : Only two samples were able to be validated because of unsuccessful cDNA sequencing at this locus for some samples.
  3. §: DASE were confirmed by sequencing in total 31 out of 39 samples whose cDNA sequencings were successful.